Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
2008
Leitung: Prof. Dr. Danilo Fliser

Publikationen 2008

Sester, U.
Hyperkaliämie - ein nephrologischer Notfall
Der Nephrologe, Springer, 22.08.2008, Band 3, Nr. 5, Seiten 366-374

 

Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Nephrol Dial Transplant. 2008 Jul;23(7):2386-92. Epub 2008 Feb 7. Impact Punkte: 3.167

 

Widmann, T., Sester, U., Gärtner, B.C., Schubert, J., Pfreundschuh, M., Köhler, H., and Sester, M.
Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
PLoS ONE 2008 3(11): e3634PDF

 

Warncke, J., David, S., Kumpers, P., Opherk, J.P., Haller, H., and Fliser, D.
A hibernating kidney - ischemic preconditioning in a renal transplant recipient with a proximal stenosis of the iliac artery.
Clin Nephrol 70:168-171. 2008 Impact Punkte: 1.320.

 

Ulrich, C., Heine, G.H., Gerhart, M.K., Köhler, H., and Girndt, M.
Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients.
Am J Transplant 8:103-110. 2008 Impact Punkte: 6.423.

 

Sester, U., Presser, D., Dirks, J., Gartner, B.C., Köhler, H., and Sester, M.
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.
Am J Transplant 8:1486-1497. 2008 Impact Punkte: 6.423.

 

Sester, M., Gärtner, B.C., and Sester, U.
Monitoring of CMV-specific T-cell levels after organ transplantation.
J Lab Med 2008. 32:121-130. 2008

 

Sester, M., Gärtner, B.C., Girndt, M., and Sester, U.
Vaccination of the solid organ transplant recipient.
Transplant Rev (Orlando) 22:274-284. 2008

 

Seiler, S., Schlitt, A., Jiang, X.C., Ulrich, C., Blankenberg, S., Lackner, K.J., Girndt, M., Werdan, K., Buerke, M., Fliser, D., and Heine, G.H.
Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
Nephrol Dial Transplant 23:3599-3604. 2008 Impact Punkte: 3.167.

 

Scheller, N., Furtwängler, R., Sester, U., Maier, R., Breinig, T., and Meyerhans, A.
Human cytomegalovirus protein pp65: an efficient protein carrier system into human dendritic cells.
Gene Ther 15:318-325. 2008 Impact Punkte: 4,782.

 

Menz, B., Sester, M., Koebernick, K., Schmid, R., and Burgert, H.G.
Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
Mol Immunol 46:16-26. 2008 Impact Punkte: 3.742.

 

McSharry, B.P., Burgert, H.G., Owen, D.P., Stanton, R.J., Prod'homme, V., Sester, M., Koebernick, K., Groh, V., Spies, T., Cox, S., Little, A.M., Wang, E.C., Tomasec, P., and Wilkinson, G.W.
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.
J Virol 82:4585-4594. 2008 Impact Punkte: 5.332. PDF

 

Link, A., Girndt, M., Selejan, S., Rbah, R., and Böhm, M.
Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.
Crit Care 12:R111. 2008 Impact Punkte: 3.834.

 

Kielstein, J.T., Salpeter, S.R., Buckley, N.S., Cooke, J.P., and Fliser, D.
Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants.
Kidney Blood Press Res 31:259-267. 2008 Impact Punkte: 1.092.

 

Heine, G.H., Ulrich, C., Seibert, E., Seiler, S., Marell, J., Reichart, B., Krause, M., Schlitt, A., Kohler, H., and Girndt, M.
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.
Kidney Int 73:622-629. 2008 Impact Punkte: 4.922.

 

Girndt, M.
Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.
Drugs Aging 25:823-840. 2008 Impact Punkte: 2.140.

 

Fliser, D., and Bahlmann, F.H.
Erythropoietin and the endothelium - a promising link?
Eur J Clin Invest 38:457-461. 2008 Impact Punkte: 2.701.

 

Fliser, D.
The kidneys and old age.
Dtsch Med Wochenschr 133:1835-1838. 2008 Impact Punkte: 0.433.

 

Fliser, D.
Assessment of renal function in elderly patients.
Curr Opin Nephrol Hypertens 17:604-608. 2008 Impact Punkte: 4.146.

 

Egli, A., Binet, I., Binggeli, S., Jager, C., Dumoulin, A., Schaub, S., Steiger, J., Sester, U., Sester, M., and Hirsch, H.H.
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.
J Transl Med 6:29. 2008 Impact Punkte: 2.935. PDF

 

Dinser, R., Fousse, M., Sester, U., Albrecht, K., Singh, M., Kohler, H., Muller-Ladner, U., and Sester, M.
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
Rheumatology (Oxford) 47:212-218. 2008 Impact Punkte: 4.045. PDF

 

de Groot, K., Kuklik, K., Brocker, V., Schwarz, A., Gwinner, W., Kreipe, H., Haller, H., Fliser, D., and Mengel, M.
Toll-like receptor 2 and renal allograft function.
Am J Nephrol 28:583-588. 2008 Impact Punkte: 2.182.

 

David, S., Kumpers, P., Seidler, V., Biertz, F., Haller, H., and Fliser, D.
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
Nephrol Dial Transplant 23:1370-1377. 2008 Impact Punkte: 3.167.

 

Burkhardt, O., Hafer, C., Langhoff, A., Kaever, V., Kumar, V., Welte, T., Haller, H., Fliser, D., and Kielstein, J.T.
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
Nephrol Dial Transplant. 2008 Impact Punkte: 3.167.

 

Bahlmann, F.H.
Use of erythropoietin for cardiovascular protection.
Cardiovasc Drugs Ther 22:253-255. 2008 Impact Punkte: 1.856.